Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v4-FR
Language French French
Date Updated 2020-12-22 2020-12-22
Drug Identification Number 02212226 02212226
Brand name FORTAZ FORTAZ
Common or Proper name Ceftazidime Ceftazidime
Company Name GLAXOSMITHKLINE INC GLAXOSMITHKLINE INC
Ingredients CEFTAZIDIME CEFTAZIDIME
Strength(s) 2G 2G
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size All pack sizes / Tous les formats All pack sizes / Tous les formats
ATC code J01DD J01DD
ATC description OTHER BETA-LACTAM ANTIBACTERIALS OTHER BETA-LACTAM ANTIBACTERIALS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2020-12-21 2020-12-21
Remaining supply date 2018-05-31 2018-05-31
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Information on remaining supply
Company comments
Health Canada comments